Skip to main content
OpenTrials
Completed

NCT Number: NCT05236725

Monitoring and Testing of Blood Pressure in Postpartum Women

The purpose of this research study is to find out the usefulness of checking a woman's blood pressure remotely (at home) for 3 weeks after being discharged from the hospital after having a baby (or babies). Some women can develop hypertension, or high blood pressure, after delivery even if they have not had this problem before or during their pregnancy. Untreated or unknown high blood pressure can lead to medical complications, and if severe, can be life threatening. Monitoring, or checking, remote blood pressure after a woman has delivered her baby (or babies) has been suggested to be a better way to monitor blood pressures without having to stay in the hospital for a longer time after delivery. Other researchers report that women who have checked their blood pressure remotely after delivery found out that this was both possible and acceptable.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, 27157, United States

About this study

This is a randomized control trial. All women, 18 years of age and older, delivering an infant(s) at The Birth Center at Atrium Health Wake Forest Baptist and residing in Forsyth County, North Carolina that have been approached by our Home Visit Coordinators will be eligible for enrollment and invited to participate in the SMART-BP study prior to discharge from the postpartum unit. Per established protocols, the Home Visit Coordinators for the Nurse Education Support Team Program attempt to approach all women that deliver in The Birth Center and who reside in Forsyth County. At this initial introduction, the Home Visit Coordinators determine if the patient has any need for, or interest in, any of the vetted community resources available to her and her family. Information about any of these resources are provided to the patient at that time. Additionally, the Home Visit Coordinators offer to schedule a nurse "home visit." This nurse home visit occurs via phone call, telehealth visit, or an in person visit approximately 2 weeks after delivery.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women that received prenatal care at one of the Atrium Health Wake Forest Baptist Obstetrics/Maternal-Fetal Medicine outpatient clinic locations in Forsyth County, North Carolina
  • Women that delivered an infant(s) at The Birth Center at Atrium Health Wake Forest Baptist
  • Women that delivered an infant(s) at home or outside facility, and were transported to Atrium Health Wake Forest Baptist and received postpartum care in The Birth Center
  • Currently resides in Forsyth County, North Carolina
  • Able to read and understand either English or Spanish
  • Owns or has daily access to a smart phone (iOS or Android operating system) with available Wi-Fi or monthly mobile data plan

Exclusion criteria

  • Women that received postpartum care at any location other than The Birth Center at Atrium Health Wake Forest Baptist
  • Resides outside of Forsyth County, North Carolina
  • Under 18 years of age
  • Unable to read or understand either English or Spanish
  • Does not own or have daily access to a smart phone (iOS or Android operating system) with available Wi-Fi or monthly mobile data plan

Treatment and study plan

Remote Blood Pressure Cuff

Device

specialized, Bluetooth enabled blood pressure monitoring cuff

Blood pressure monitoring smart phone app, BabyScripts™

Device

app that works with the monitoring cuff

Instructions

Behavioral

Verbal and written instructions to conduct blood pressure checks at home

Primary outcomes

  1. Median Number of Remote Blood Pressure (rBPM) Measurements Obtained Per Participant

    Time frame: Discharge through Week 3 postpartum

    Used to determine feasibility of remote blood pressure monitoring intervention (rBPM) in postpartum women. This measure represents the median number of remote blood pressure monitoring (rBPM) measurements collected per participant during the study period. The total number of rBPM readings obtained for each participant was calculated, and the median value across all participants in the analysis population was reported

  2. Proportion of Participants Monitoring Blood Pressure (BP) According to American College of Obstetricians and Gynecologists (ACOG) Guidelines

    Time frame: Discharge through Day 10 postpartum

    This outcome measures the proportion of participants whose postpartum blood pressure monitoring adhered to American College of Obstetricians and Gynecologists (ACOG) recommendations. Adherence includes: Initial Monitoring (first 72 hours postpartum): inpatient or equivalent monitoring for women with pregnancy-related hypertension; and Early Follow-Up (3-10 days postpartum): documentation of a follow-up visit or remote blood pressure check within 3-10 days after hospital discharge. Monitoring data will be obtained from electronic health records and remote blood pressure monitoring logs. Participants are counted once if they met both ACOG-recommended monitoring intervals.

  3. Median Total Cost of Health Care

    Time frame: From discharge through week 8 postpartum

    Cost of hospital based medical care of subjects in US dollars.

  4. Number of Participants Experiencing at Least One Day With a Severe Hypertension Event

    Time frame: Discharge through week 1 postpartum

    This measure captures the number of participants who experienced one or more days in which a severe hypertension event occurred. A participant is counted once if they had ≥1 day meeting severe hypertension criteria, regardless of the total number of qualifying days. A severe or critical hypertensive event is defined as any blood pressure reading in which the systolic value is ≥160 mmHg and/or the diastolic value is ≥110 mmHg.

  5. Number of Participants Experiencing at Least One Day With a Severe Hypertension Event

    Time frame: Discharge through week 3 postpartum

    This measure captures the number of participants who experienced one or more days in which a severe hypertension event occurred. A participant is counted once if they had ≥1 day meeting severe hypertension criteria, regardless of the total number of qualifying days. A severe or critical hypertensive event is defined as any blood pressure reading in which the systolic value is ≥160 mmHg and/or the diastolic value is ≥110 mmHg.

  6. Number of Participants With One or More Urgent or Emergent Care Encounters

    Time frame: Discharge through week 3 postpartum

    The study team will use the electronic health record (EHR) to identify the number of participants who had one or more encounters at Emergency Department, Obstetric Triage, or Urgent Care facilities affiliated with Atrium Health Wake Forest Baptist. Encounters will be identified using visit type classifications and associated encounter codes documented in the EHR. Only encounters occurring within the specified study time frame and attributable to enrolled participants will be included. Each participant will be counted once regardless of the total number of urgent or emergent care visits they experienced.

Secondary outcomes

  1. Median Number of Encounters for Urgent or Emergent Care

    Time frame: Discharge through week 8 postpartum

    Study team will use the electronic health record to identify encounters to the Emergency Department, OB Triage, and Urgent Care facilities

  2. Acceptability of rBPM in Postpartum Period

    Time frame: Week 3 postpartum

    Survey to determine subject's level of satisfaction with use of the rBPM tools. Survey responses will be compared among subjects from varying demographic and socioeconomic groups. Survey is designed utilizing a Likert-type scale with 1-2 being higher level of acceptability, 3 being neutral, and 4-5 being lower level of acceptability of the rBPM tools. Study team will report the overall proportion and estimate the proportion of women with higher vs. lower levels of acceptability among women of different demographic and socioeconomic groups. This aim only applies to the women in the treatment (rBPM) arm.

  3. Median Length of Stay (LOS) in Hospital After Delivery

    Time frame: Baseline (date of delivery) through discharge, assessed for up to 8 weeks postpartum

  4. Median Number of Hospital Readmissions

    Time frame: Discharge through week 8 postpartum

  5. Median Length of Stay (LOS) for Hospital Readmissions

    Time frame: Discharge through week 8 postpartum

  6. Median Number of Women That Have a Follow-up Encounter Scheduled With Their Primary Care Physician (PCP) Within 12 Months After Delivery

    Time frame: Discharge through 12 months postpartum

Other outcomes

  1. Validate and Calibrate Previously Developed Predictive Algorithm

    Time frame: Discharge through week 8 postpartum

    Intended to assess the performance of the predictive algorithm in identifying postpartum high blood pressure readmissions. Study team will utilize blood pressure measures obtained through 3 weeks postpartum, as well as any hypertensive disorders of pregnancy events postpartum through 8 weeks postpartum, to include Emergency Department/Urgent Care/Obstetrics Triage encounters and any readmissions. The predictive algorithm is informed by information documented in the electronic health record, prior to delivery and during pregnancy.

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Registry information

Official study title

Systematic Monitoring and Remote Testing of Blood Pressure in Postpartum Women

Acronym: SMART-BP

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Feb 11, 2022
Registry last updated
Mar 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.